Lokman Hekim Health Sciences
Article Open Access Volume 1 · Issue 3 · 2021 pp. 89–99

Bromelain, a Potential Therapeutic Compound from Ananas Comosus

Aydın Alper Şahin- ORCID
1 Department of Pharmaceutical Product, Certification Unit, Turkish Medicine and Medical Devices Agency, Ankara, Turkey
Published: 2021 DOI: 10.14744/lhhs.2021.10001 Article ID: LHHS-56789
Abstract
Bromelain is a mixture of enzymes found in crude extract from the fruit and other parts of the pineapple Ananas comosus (Linn.), Bromeliaceae family. Bromelain is a nontoxic compound having various industrial and therapeutic applications. It consists of varied closely related proteinases that are important as anti-inflammatory, antithrombotic, and fibrinolytic agents. Bromelain is widely administered for its well-known properties, such as anticancer activity, antioxidant activity, and immunomodulatory effects. It also plays a major role in the modulation of the immune system and prevents the harmful effects of the cytokine storm. Because of all these therapeutic effects, bromelain appears to be a potential candidate to inhibit and prevent the symptoms of different diseases as well being an effective, natural, therapeutic weapon for the treatment of severe COVID-19 infection.

Keywords: Bromelain; Enzymes; COVID-19

Article information

3,637 Views
3,636 Downloads
View / Download PDF

Current Issue Vol 1 · Iss 3

Submit manuscript
Most read & early access
Click an article to open abstract.
View all articles